BASIC INFORMATION

ATC classification

Blood disorders

Category of release

On prescription

Packaging

sol. for inj., 100 mg/ml, 5 ml, No. 5х1

Storage conditions

Keep in the original packaging at a temperature not exceeding 25 °С. Do not freeze. Keep out of reach of children.

Expiration date

2 years

Back

BASIC INFORMATION

ATC classification

Blood disorders

Category of release

On prescription

Packaging

sol. for inj., 100 mg/ml, 5 ml, No. 5х1

Storage conditions

Keep in the original packaging at a temperature not exceeding 25 °С. Do not freeze. Keep out of reach of children.

Expiration date

2 years

GENERAL CHARACTERISTICS

Antihemorrhagics, antifibrinolytics, amino acids. Fibrinolysis inhibitors. ATC Code B02A A02

Indications to Use:

Bleeding or risk of bleeding with increased fibrinolysis, both generalized and local: menorrhagia, metrorrhagia, nasal, pulmonary, gastrointestinal bleeding, hematuria, bleeding during and after operations on the prostate gland, organs of the urinary tract, ENT organs (adenoidectomy, tonsillectomy, extraction of teeth), on the organs of the thoracic and abdominal cavities, during and after gynecological operations, obstetric manipulations and other surgical interventions, in cardiovascular surgery, bleeding with pregnancy postpartum bleeding, manual detachment, chorion-free prescription, malignant neoplasm of the pancreas and prostate gland, hemophilia, bleeding after prostatectomy, conization of the cervix for carcinoma, thrombocytopenic purpura, leukemia, liver disease, previous therapy with streptokinase. Surgical manipulations at a systemic inflammatory reaction (sepsis, peritonitis, pancreatic necrosis, severe and moderate severity of gestosis, shock of various etiologies and other critical conditions). Hemorrhagic complications in fibrinolytic therapy.

Your message was successfully sent

Feedback Form